AI Insight
A clinical trial is investigating whether high doses of vitamin B3 (niacin) can improve outcomes for glioblastoma patients by reactivating immune cells that are typically suppressed by the tumor. The treatment aims to restore the ability of these immune cells to effectively target and attack cancer cells. Preliminary data shows patients experienced better progression-free survival compared to standard expectations for this aggressive brain cancer.
Why it matters
Glioblastoma is one of the most lethal brain cancers with very limited treatment options and poor survival rates. If high-dose vitamin B3 proves effective, it could offer a relatively accessible and potentially less toxic complementary treatment approach to enhance the immune system's natural cancer-fighting capabilities.
Understand the Science
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to attack cancer more effectively. Early results have been promising, with patients showing significantly better progression-free survival than expected.
Source: A common vitamin could help fight one of the deadliest brain cancers